The differing time–action profiles provided by these long-acting MPH formulations may allow clinicians to target specific periods of the day that are particularly relevant for a patient ...

Concerta and Teva Pharma Australia's modified-release methylphenidate hydrochloride tablets are in low supply, with stock expected to remain scarce for months. It's the last thing parents of children ...